Single

Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty

Conditions:   Total Knee Arthroplasty;   Pain, Postoperative;   Adductor Canal BlockInterventions:   Procedure: Multimodal Peripheral Nerve Block Injection;   Procedure: Single Shot Adductor Canal BlockSponsor:   Wake Forest School of MedicineNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.

Condition:   Asthma, Chronic Obstructive Pulmonary Disease (COPD)Interventions:   Drug: Treatment A – AZD7594;   Drug: Treatment B – AZD7594;   Drug: Treatment C – AZD7594Sponsor:   AstraZenecaNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.

Condition:   Asthma, Chronic Obstructive Pulmonary Disease (COPD)Interventions:   Drug: Treatment A – AZD7594;   Drug: Treatment B – AZD7594;   Drug: Treatment C – AZD7594Sponsor:   AstraZenecaNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Condition:   Bronchial AsthmaInterventions:   Drug: Intravenous magnesium sulfate;   Drug: Inhaled budesonide;   Drug: normal salineSponsor:   Hamad Medical CorporationRecruiting – verified May 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma

Conditions:   Healthy;   AsthmaInterventions:   Drug: JNJ-43260295;   Drug: Placebo;   Other: Nasal Allergen ChallengeSponsor:   Janssen Research & Development, LLCNot yet recruiting – verified September 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Condition:   Duchenne’s Muscular DystrophyIntervention:   Biological: Umbilical Cord Mesenchymal Stem CellsSponsors:   Allergy and Asthma Consultants, Wichita, KansasAidan Foundation;   Neil H. Riordan PhDAllergy and Asthma Consultants, Wichita, KansasEnrolling by invitation – verified September 2014 View full post on ClinicalTrials.gov: asthma | received in the last…